# ImmunityBio, Inc.: Form 8-K, filed Dec 5, 2022

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2022-12-05
- Accepted by EDGAR: Dec 5, 2022, 10:51 ET
- Period: 2022-12-02
- Accession: 0001326110-22-000076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000132611022000076/ibrx-20221202.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000132611022000076/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000132611022000076/ibrx-20221202.htm

Filed Dec 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001326110-22-000076. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
